Browse hierarchy: [Gastroenterology, Urology (GU)](/submissions/GU) → [Subpart B — Diagnostic Devices](/submissions/GU/subpart-b%E2%80%94diagnostic-devices) → [21 CFR 876.1450](/submissions/GU/subpart-b%E2%80%94diagnostic-devices/876.1450) → QIS — Esophageal, Mucosal, Electrical Characterization

# QIS · Esophageal, Mucosal, Electrical Characterization

_Gastroenterology, Urology · 21 CFR 876.1450 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/GU/subpart-b%E2%80%94diagnostic-devices/QIS

## Overview

- **Product Code:** QIS
- **Device Name:** Esophageal, Mucosal, Electrical Characterization
- **Regulation:** [21 CFR 876.1450](/submissions/GU/subpart-b%E2%80%94diagnostic-devices/876.1450)
- **Device Class:** 2
- **Review Panel:** [Gastroenterology, Urology](/submissions/GU)

## Identification

An esophageal tissue characterization system is a device intended for obtaining measurements of electrical properties within esophageal tissue.

## Classification Rationale

Class II (special controls). The special controls for this device are:

## Special Controls

*Classification.* Class II (special controls). The special controls for this device are:(1) All patient contacting components of the device must be demonstrated to be biocompatible.
(2) Performance testing must demonstrate the device can accurately measure the designated electrical characteristics.
(3) Mechanical safety testing must demonstrate that the device will withstand forces encountered during use.
(4) Software verification, validation, and hazard analysis must be performed.
(5) Electromagnetic compatibility and electrical safety, mechanical safety, and thermal safety of the device must be performed.
(6) Performance data must validate the reprocessing instructions for any reusable components of the device.
(7) Labeling must include:
(i) Specific instructions regarding the proper placement and use of the device;
(ii) Instructions for reprocessing of any reusable components; and
(iii) An expiration date for single use components.

## Recent Cleared Devices (3 of 3)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [K233974](https://fda.innolitics.com/submissions/GU/subpart-b%E2%80%94diagnostic-devices/QIS/K233974.md) | Mucosal Impedance Measurement System | Alandra Medical Sapi DE CV | Sep 6, 2024 | SESE |
| [K230056](https://fda.innolitics.com/submissions/GU/subpart-b%E2%80%94diagnostic-devices/QIS/K230056.md) | MiVu™ Esophageal Endo Cap | Diversatek Healthcare | Apr 25, 2023 | SESE |
| [DEN180067](https://fda.innolitics.com/submissions/GU/subpart-b%E2%80%94diagnostic-devices/QIS/DEN180067.md) | Mucosal Integrity Conductivity (MI) Test System | Diversatek Healthcare, Inc. | Dec 23, 2019 | DENG |

## Top Applicants

- Alandra Medical Sapi DE CV — 1 clearance
- Diversatek Healthcare — 1 clearance
- Diversatek Healthcare, Inc. — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/GU/subpart-b%E2%80%94diagnostic-devices/QIS](https://fda.innolitics.com/submissions/GU/subpart-b%E2%80%94diagnostic-devices/QIS)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com